Medomed Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.19 M
- Paid Up Capital ₹ 0.19 M
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth -18.54%
- Profit Growth -89.32%
- Ebitda -71.58%
- Net Worth 3.95%
- Total Assets 5.55%
About Medomed Life Science
Medomed Life Science Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 September 2015 (Nine years and four months 25 days old ). Its registered office is in Kollam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.19 M and a paid-up capital of Rs 0.19 M.
The company currently has active open charges totaling ₹1.00 M.
Vinod Pillai and Lekha Kumaresan serve as directors at the Company.
Company Details
-
Location
Kollam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397KL2015PTC039185
-
Company No.
039185
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Sep 2015
-
Date of AGM
20 Oct 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Medomed Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Pillai
|
Director | 15-Sep-2015 | Current |
|
Lekha Kumaresan
|
Director | 15-Oct-2019 | Current |
Financial Performance of Medomed Life Science.
Medomed Life Science Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 18.54% decrease. The company also saw a substantial fall in profitability, with a 89.32% decrease in profit. The company's net worth moved up by a moderate rise of 3.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medomed Life Science?
In 2022, Medomed Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hitechnical Infinity Trading And Contracting Private LimitedVinod Pillai is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jan 2017 | Others | ₹1.00 M | Open |
How Many Employees Work at Medomed Life Science?
Medomed Life Science has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medomed Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medomed Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
